← SynDRA
CB-5083
SynDRA canonical compound SYN0038536 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | VCP |
|---|
| Mechanism of action | valosin-containing protein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- valosin-containing protein inhibitor
Cross-references
Synonyms
- CB 5083
- CB5083
- CPD 71
- JDP
- RefChem:124071
- p97 Inhibitor CB-5083
- DTXCID001507227
- MFCD28963914
- UNII-591IV6UL6J
- orb1300457
- SCHEMBL15421452
- SCHEMBL18303410
- SCHEMBL29350494
- SCHEMBL30076956
- EX-A773
- CB 5083 [WHO-DD]
- CHEBI:232521
- C24H23N5O2
- GLXC-90488
- HMS3873E13
- HMS5086C07
- BDBM50500325
- NSC786100
- AKOS025396184
- CCG-268805
- CS-5405
- EBC-216021
- NSC-786100
- NCGC00481317-01
- NCGC00481317-02
- NCGC00481317-03
- AC-29018
- AS-55872
- BC177445
- CB-5083?
- DA-71987
- HY-12861
- S8101
- T6796
Look up CB-5083 in the interactive SynDRA portal →